Share on StockTwits

Stock analysts at Canaccord Genuity hoisted their price objective on shares of HeartWare International (NASDAQ:HTWR) from $121.00 to $125.00 in a report issued on Friday, American Banking and Market News reports. Canaccord Genuity’s price target indicates a potential upside of 31.58% from the stock’s previous close.

Shares of HeartWare International (NASDAQ:HTWR) opened at 95.00 on Friday. HeartWare International has a 52 week low of $69.31 and a 52 week high of $105.84. The stock has a 50-day moving average of $89. and a 200-day moving average of $91.51. The company’s market cap is $1.610 billion.

HeartWare International (NASDAQ:HTWR) last posted its quarterly earnings results on Thursday, May 1st. The company reported ($1.15) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.90) by $0.25. Analysts expect that HeartWare International will post $-2.98 EPS for the current fiscal year.

A number of other firms have also recently commented on HTWR. Analysts at Oppenheimer upgraded shares of HeartWare International from a “market perform” rating to an “outperform” rating in a research note on Monday, April 14th. Separately, analysts at BTIG Research upgraded shares of HeartWare International from a “neutral” rating to a “buy” rating in a research note on Monday, April 14th. They now have a $100.00 price target on the stock. Finally, analysts at Goldman Sachs downgraded shares of HeartWare International from a “neutral” rating to a “sell” rating in a research note on Monday, April 14th. They now have a $73.00 price target on the stock, down previously from $94.00. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company’s stock. HeartWare International currently has an average rating of “Buy” and a consensus target price of $108.10.

In other HeartWare International news, Insider Jeffrey Larose unloaded 2,179 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $89.96, for a total transaction of $196,022.84. The sale was disclosed in a document filed with the SEC, which is available at this link.

Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.